# Braskem SA: overview BAK · NYSE · CIK 1071438 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bak.md) · [Financials](/companies/bak/financials.md) · [Filings](/companies/bak/filings.md) · [Insiders](/companies/bak/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [58.5](/filings/0001292814-23-001738.md) | [106](/filings/0001292814-24-001348.md) | [96.5](/filings/0001292814-25-001192.md) | [70.6](/filings/0001292814-25-001192.md) | [77.4](/filings/0001292814-25-001192.md) | | Gross margin | % | [19.2%](/filings/0001292814-23-001738.md) | [30.3%](/filings/0001292814-24-001348.md) | [11.8%](/filings/0001292814-25-001192.md) | [4.3%](/filings/0001292814-25-001192.md) | [7.7%](/filings/0001292814-25-001192.md) | | Operating margin | % | [(0.1%)](/filings/0001292814-23-001738.md) | [24.7%](/filings/0001292814-24-001348.md) | [4.4%](/filings/0001292814-25-001192.md) | [(4.0%)](/filings/0001292814-25-001192.md) | [(1.4%)](/filings/0001292814-25-001192.md) | | Net margin | % | [(11.4%)](/filings/0001292814-23-001738.md) | [13.2%](/filings/0001292814-24-001348.md) | [(0.3%)](/filings/0001292814-25-001192.md) | [(6.5%)](/filings/0001292814-25-001192.md) | [(14.6%)](/filings/0001292814-25-001192.md) | | Diluted EPS | $ per share | [(8.41)](/filings/0001292814-22-001862.md) | [17.57](/filings/0001292814-22-001862.md) | not reported | not reported | not reported | | Free cash flow | $bn | [3.5](/filings/0001292814-23-001738.md) | [11.4](/filings/0001292814-24-001348.md) | [4.1](/filings/0001292814-25-001192.md) | [(6.8)](/filings/0001292814-25-001192.md) | [(1.3)](/filings/0001292814-25-001192.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bak/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [140 Summer Partners LP](/funds/1820788.md) | 2026-06-30 | $19.6m | 8,030,124 | | New +8,030,124 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $4.9m | 2,019,382 | | Added +1,338,983 | | [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $3.7m | 1,519,411 | | New +1,519,411 | | [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $3.0m | 1,233,885 | | Added +1,182,683 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $2.0m | 821,977 | | Added +44,850 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $2.0m | 820,304 | | Added +301,479 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $1.9m | 760,743 | | Added +300,780 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.2m | 485,679 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $779.3k | 319,404 | | Reduced −5,618 | | [Marex Group Ltd](/funds/1997464.md) | 2026-06-30 | $732.0k | 300,000 | | New +300,000 | ## Recent filings [All 2,264 filings](/companies/bak/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 21:53 ET | [6-K](/filings/0001292814-26-005020.md) | Report of a foreign private issuer, period 2026-12-31 | 0001292814-26-005020 | | 2026-10-26 | 08:16 ET | [6-K](/filings/0001292814-26-005004.md) | Report of a foreign private issuer, period 2026-12-31 | 0001292814-26-005004 | | 2026-10-22 | 21:15 ET | [6-K](/filings/0001292814-26-004980.md) | Report of a foreign private issuer, period 2026-12-31 | 0001292814-26-004980 | | 2026-10-22 | 21:11 ET | [6-K](/filings/0001292814-26-004978.md) | Report of a foreign private issuer, period 2026-12-31 | 0001292814-26-004978 | | 2026-10-22 | 20:12 ET | [6-K](/filings/0001292814-26-004976.md) | Report of a foreign private issuer, period 2026-12-31 | 0001292814-26-004976 | | 2026-10-13 | 19:56 ET | [6-K](/filings/0001292814-26-004904.md) | Report of a foreign private issuer, period 2026-09-30 | 0001292814-26-004904 | | 2026-10-13 | 19:52 ET | [6-K](/filings/0001292814-26-004902.md) | Report of a foreign private issuer, period 2026-09-30 | 0001292814-26-004902 | | 2026-09-28 | 19:26 ET | [6-K](/filings/0001292814-26-004716.md) | Report of a foreign private issuer, period 2026-09-30 | 0001292814-26-004716 | | 2026-09-25 | 09:05 ET | [6-K](/filings/0001292814-26-004695.md) | Report of a foreign private issuer, period 2026-09-30 | 0001292814-26-004695 | | 2026-09-11 | 19:04 ET | [6-K](/filings/0001292814-26-004530.md) | Report of a foreign private issuer, period 2026-09-30 | 0001292814-26-004530 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001292814-26-002427.md), filed Apr 20, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1071438 - Tickers: BAK - Exchange: NYSE - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: not reported - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 06:09 ET. No prices; not investment advice.